Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enavogliflozin PK/PD evaluation in healthy Brazilian adults
RBR-8ks2vwnPhase 1Not yet recruiting
- Sponsor
- Synvia
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of enavogliflozin in type 2 diabetes mellitus (T2DM) (6 arms), sponsored by Synvia. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
enavogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on RBR-8ks2vwn.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8ks2vwn.